[ad_1]
<p class = "canvas-atom canvas-text Mb (1.0em) Mb (0) – sm Mt (0.8em) – sm" type = "text" content = "Currently, the centers of control and prevention of diseases say & nbsp;130 people in the United States die every day opioids. Americans & nbsp;are now more likely to be killed& nbsp; opioids only in a car accident. "Data-reactid =" 16 "> Currently, the Centers for Disease Control and Prevention say that 130 people die every day in the United States of opioids.The Americans are now more likely to be killed by opioids in a car accident.
<p class = "canvas-atom canvas-text Mb (1.0em) Mb (0) – sm Mt (0.8em) – sm" type = "text" content = "This epidemic is the symptom of deep problems in our country – including stress, income inequality and social mobility – which & nbsp;I've recently been diving in a bit.& nbsp; It will take a lot of time and work to solve these problems. But the opioid crisis must also be addressed at a more micro and immediate level. "Data-reactid =" 17 "> This epidemic is a symptom of profound problems in our country – including stress, income inequality and social mobility – that I've recently explored a little bit about the issue: it will take a lot of time and work to solve these problems, but the opioid crisis must also be addressed at a more micro and more immediate level.
And this last point is leading us to the pharmaceutical sector because, of course, the opioid crisis is a shocking shame for a group of drug manufacturers and distributors who have imposed on our society addictive narcotics at levels well beyond any plausible medical need.
<p class = "web-atom canvas-text Mb (1.0em) Mb (0) – sm Mt (0.8em) – sm" type = "text" content = "There are a lot of ways to show it. Here is a fact that sums up the situation well: the United States accounts for about 4.5% of the world's population, but according to data from the International Narcotics Control Board, which monitors the global use of opioids, the & nbsp;The United States consumed 72.9% of oxycodone (or oxycontin) worldwide in 2016. Explain that Mr. Pharma is a leader. "Data-reactid =" 19 "> There are many ways to show it, but here's a fact that sums it up: the United States accounts for about 4.5% of the world's population. International Narcotics Control, which monitors global opioid consumption, the United States consumed 72.9% of oxycodone (or oxycontin) in the world in 2016. Explain What is M. Pharma .
Invest in companies that are part of the solution
The guilt of these companies is now the subject of a judicial decision, but a certain degree of responsibility has already been established. These companies have contributed to causing this scourge.
A sign bearing certain names of the Sackler family is on display at the Metropolitan Museum of Art in New York on Thursday, January 17, 2019. (AP Photo / Seth Wenig)
I'm sure you hesitate to say how terrible it is, but let me ask you a question: Do you own any shares of companies belonging to the opioid ecosystem?
<p class = "canvas-atom canvas-text Mb (1.0em) Mb (0) – sm Mt (0.8em) – sm" type = "text" content = "In terms of society at the center of this storm, the answer is almost certainly not, because Purdue Pharma, a brand of Oxycontin, is a private company of the Sackler family, which now faces all kinds of litigation, including a & nbsp;lawsuit filed last week& nbsp; by the Attorney General of New York accusing him of creating an epidemic of opioids that ravaged the state and caused "widespread dependence, overdose deaths and suffering." The Sacklers suffered further setbacks, & nbsp;including prestigious museums where the family has made significant donations putting an end to these relationships."Data-reactid =" 43 "> Regarding the company at the center of this storm, the answer is almost certainly no, because Purdue Pharma, brand of Oxycontin, is a private company of the Sackler family. types of litigation, including a lawsuit filed last week by the New York Attorney General accusing him of having created an epidemic of opioids that ravaged the state and provoked "a widespread addiction, overdose deaths and suffering. "The Sacklers have suffered other setbacks, including profile museums where the family has made significant donations ending these relationships.
<p class = "canvas-atom canvas-text Mb (1.0em) Mb (0) – sm Mt (0.8em) – sm" type = "text" content = "But what about other companies who manufacture opioids? Endo Health Solutions, Cephalon, a subsidiary of Teva Pharmaceutical Industries, Janssen Pharmaceuticals, a subsidiary of Johnson & Johnson, and Allergan, formerly known as Actavis, and another group of complicit companies, distributors , mainly, Amerisource Bergen, Cardinal Health and McKesson, who would have profited from the sale of ridiculous & nbsp;amounts of opioids in the pills mills& nbsp; around the United States "data-reactid =" 44 "> But what about other companies manufacturing opioids? There is Endo Health Solutions, Cephalon, a subsidiary of Teva Pharmaceutical Industries, Janssen Pharmaceuticals, a subsidiary of Johnson & Johnson, and Allergan, formerly known as Actavis.There is another group of complicit companies, distributors, primarily Amerisource Bergen, Cardinal Health and McKesson, who would have benefited from the sale of ridiculous amounts of money. Opioids at pills manufacturing plants in the United States.
It is not improbable that you own one or more of these stocks in your portfolio, mutual fund or ETF. If you have invested in companies that are part of the problem – or even if you have not done so – have you considered investing in companies that could be part of the solution?
Richard Pops, CEO of Alkermes, Inc., presents a human brain model in his Cambridge, Mass., Business on Wednesday, August 3, 2005. Alkermes Inc., based in Cambridge, expects to receive news from the federal regulatory authorities by September 30 its application to market its new drug, Vivitrex, to doctors specializing in the treatment of drug addiction. (AP Photo / Suzuki Chitose)
<p class = "canvas-atom canvas-text Mb (1.0em) Mb (0) – sm Mt (0.8em) – sm" type = "text" content = "First of all, know that more than 39 opportunities appear for these companies The FDA has & nbsp;called& nbsp; for better access to medicines for the treatment of opioid dependence. And last October, President Donald Trump & nbsp;sign& nbsp; an opioid bill that "lifts restrictions on drugs for opioid addiction, allowing more types of health professionals to prescribe drugs," according to & nbsp;Vox. Senator Elizbeth Warren, Democrat of Massachusetts and presidential candidate of 2020, & nbsp;introduced& nbsp; CARE Act of last year on the fight against the opioid epidemic. "data-reactid =" 71 "> First, be aware that new opportunities are emerging for these companies.The FDA has called for better access to drugs for the treatment of opioid dependence.And last October. , President Donald Trump has signed an opioid bill that "lifts restrictions on drugs for opioid addiction, allowing more types of health practitioners to prescribe drugs," said Senator Elizbeth Warren, Democrat of Massachusetts and 2020 presidential candidate, introduced the CARE law last year to combat the opioid epidemic.
So why has there been so much resistance to what is known as opioid dependence treatment (ART)?
"We need a dramatic action"
<p class = "canvas-atom canvas-text Mb (1.0em) Mb (0) – sm Mt (0.8em) – sm" type = "text" content = "Keith Humphreys, PhD, researcher at the University Stanford and author of & nbsp;study& nbsp; who discovered that a combination of therapeutic approaches could save thousands of lives over the next decade, explains that the problems go back to methadone, used for the first time in the treatment of opioid dependence in the 1960s "It was politicized, there were demonstrations of right and left against methadone," he says. "There are also clinics that do bad things. Who are negligent in the prescription. The government has responded by applying a fierce level of regulation. And it just stayed a little there. "" Data-reactid = "74"> Keith Humphreys, PhD, a researcher at Stanford University and author of a study that revealed that a combination of treatment approaches could save thousands of lives over the next decade, explains that the problems go back to methadone, used for the first time in the treatment of opiate addiction in the 1960s. "It was politicized, there were protests from right-to-left against methadone, "he says There are also clinics that are doing the wrong thing, all of which the government has responded by applying a fierce level of regulation, which has remained sort of there."
However, consider the dependence on other diseases: "If we had the same level of effective cancer chemotherapy as effective anticancer drugs, there would be riots in the streets," says Humphreys. "People would not tolerate that few patients with cancer receive effective treatment. Because of the negative feelings people have toward addicts, stigma and stigma, this appalling situation persists. As a result, the lives of people who could be saved instead needlessly die. "
Surveillance and regulation of these drugs is currently expensive. "The amount of monitoring is amazing and it does not have to be like that," says Humphreys. "We have distributed a lot of Oxycontin, which is more dangerous and with less regulation."
This photo taken on October 19, 2016 at the Family Guidance Center, an addiction treatment center in Joliet, IL, shows the packaging of Vivitrol, a high-priced monthly injection used to prevent relapse in opioid consumers. US prisons are currently testing these drugs, which could help drug-using inmates avoid using heroin or other opioid drugs after they are released. (AP Photo / Carla K. Johnson)
<p class = "canvas-atom canvas-text Mb (1.0em) Mb (0) – sm Mt (0.8em) – sm" type = "text" content = "So back to the companies that make drugs that The society of Biotechnology Alkermes is headquartered in Dublin, Ireland, and its shares, now trading at $ 36, have been spread over the last five years, with a market capitalization of $ 5.7 billion. Last year, Vivitrol sales increased by 11% to $ 83.8 million this year & nbsp;Alkermes expects Vivitrol's sales to reach $ 330 million to $ 350 million.& nbsp; (The company had a total turnover of $ 1 billion last year.) Vivitrol is expensive and & nbsp;In November, Senator Kamala Harris (D-Calif.) Opened an investigation into the company's business practices."data-reactid =" 97 "> So let's go back to the companies that manufacture drugs that treat drug addiction Firstly, the biotech company Alkermes is headquartered in Dublin, Ireland, with a market capitalization of 5.7 billion, did not make a profit recently, but Vivitrol sales rose 11% to $ 83.8 million.The company achieved a total turnover of $ 1 billion. last year.) Vivitrol is expensive, and in November, Senator Kamala Harris (D-Calif.) opened an investigation into her marketing practices.
<p class = "canvas-atom web-text Mb (1.0em) Mb (0) – sm Mt (0.8em) – sm" type = "text" content = "Indivior, based in Virginia, is a producer of The company was separated from the British giant Reckitt Benckiser in 2014 and has a market capitalization of $ 726 million.The title lost half of its value the day a court ruled in favor of a company seeking to develop a generic version of Suboxone in November Indivior & nbsp;is based primarily on the sales revenue of its drug Suboxone in the United States – a country that accounts for 80% of its revenues."data-reactid =" 98 "> Indivior, headquartered in Virginia, is a drug producer called Suboxone, which was sold by British giant Reckitt Benckiser in 2014 and has a market capitalization of $ 726 million. lost half of its value.On the day a court ruled in favor of a company seeking to develop a generic version of Suboxone in November, Indivior mainly relies on sales revenue of his drug Suboxone in the United States – a country that accounts for 80% of his income.
Again, these companies may not be slam dunks, but they are worth exploring. And if you're wondering whether it's bad to invest in companies that benefit from drug treatment, do not worry. "It does not bother me that people who save the lives of drug addicts are making money, like saving people with cancer," says Humphreys. "Methadone is a generic medicine, less than a dollar a day."
Right. And the government needs to move faster and give people better access to treatment such as these drugs. "[We] need a dramatic action, "says Humphreys. "[We] necessary dramatic action to reverse the AIDS epidemic, [and we] need dramatic action to reverse the situation. "
Amen to that.
<p class = "canvas-atom canvas-text Mb (1.0em) Mb (0) – sm Mt (0.8em) – sm" type = "text" content = "Andy Serwer is editor-in-chief of Yahoo Finance."data-reactid =" 102 ">Andy Serwer is editor-in-chief of Yahoo Finance.
<p class = "canvas-atom canvas-text Mb (1.0em) Mb (0) – sm Mt (0.8em) – sm" type = "text" content = "Read more:"data-reactid =" 103 ">Read more:
<p class = "canvas-atom canvas-text Mb (1.0em) Mb (0) – sm Mt (0.8em) – sm" type = "text" content = "Why do not Facebook, Google and Twitter want to be media companies?"data-reactid =" 104 "> Why do not Facebook, Google and Twitter want to be media companies?
<p class = "canvas-atom canvas-text Mb (1.0em) Mb (0) – sm Mt (0.8em) – sm" type = "text" content = "A simple but radical solution to solve Facebook problems"data-reactid =" 105 "> A simple but radical solution to solve Facebook problems
<p class = "canvas-atom canvas-text Mb (1.0em) Mb (0) – sm Mt (0.8em) – sm" type = "text" content = "How Donald Trump strengthened the New York Times and the fortune of a billionaire"data-reactid =" 106 "> How Donald Trump strengthened the New York Times and strengthened the fortune of a billionaire
[ad_2]
Source link